Sotac Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 257.44 million compared to INR 196.51 million a year ago. Revenue was INR 263.51 million compared to INR 196.61 million a year ago. Net income was INR 9.04 million compared to INR 5.71 million a year ago. Basic earnings per share from continuing operations was INR 0.82 compared to INR 0.29 a year ago.
For the nine months, sales was INR 773.86 million compared to INR 593.99 million a year ago. Revenue was INR 780.53 million compared to INR 596.13 million a year ago. Net income was INR 26.38 million compared to INR 17.9 million a year ago. Basic earnings per share from continuing operations was INR 2.41 compared to INR 2.22 a year ago.